Parkinson’s disease is a neurological disorder that can be treated by modulating the activity of D2R and A2AR. However, the identification of dual-target ligands of A2AR and D2R is challenging because of the lack of similarity between the binding sites of the receptors35. This evidence concerns the gene ADORA2A and Parkinson disease.